EUVIMEDEUVIMED entdecken
Vergleichsstudie

Head to head comparison of 18F-FDG and Al18F-NOTA-FAPI-04 PET/CT imaging used in diagnosis of autoimmune rheumatic diseases

Yuan Li, Yunshan Zhou, Jing He, Jinchuan Chen, Hua Zhu, Zhi Yang, Qian Wang, Nan Li

Clinical Rheumatology · 2024

DOI: 10.1007/s10067-024-07155-4 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Yuan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing, NMPA Key Laboratory for Research and Evaluation of Radiop…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Rheumatic Diseases, Autoimmune Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Peking University People's Hospital scientific research development funds, Peking University People’s Hospital scientific research development funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The aim of this study was to determine the performance of radionuclide-labeled fibroblast activation protein inhibitors (Al18F-NOTA-FAPI-04) PET/CT in patients with autoimmune rheumatic diseases (ARDs) and compare it with fluorine-18 (18F) labeled fluorodeoxyglucose (FDG) imaging. METHODS: Fifty-eight participants with ARDs were prospectively enrolled from April 2022 to February 2024 and underwent dual-tracer PET/CT imaging. For both 18F-FDG and Al18F-NOTA-FAPI-04 PET/CT, imaging findings were interpreted and compared. The clinical significance was compared between18F-FDG PET/CT and Al18F-NOTA-FAPI-04 PET/CT imaging. RESULTS: 18F-FDG imaging was positive in 53 out of 58 cases (91.4%) while Al18F-NOTA-FAPI-04 imaging was positive in 55 out of 58 cases (94.8%). Overall positive rate of Al18F-NOTA-FAPI-04 imaging was as high as 18F-FDG imaging (P = 0.625). 18F-FDG imaging detected more lesions in lymph node, spleen, and bone marrow. Al18F-NOTA-FAPI-04 imaging detected more lesions in the lung, muscle, and tendon/ligament. There was no statistical difference of composing ratio of grades of clinical significance between two imaging modalities (χ2 = 2.875, P = 0.238). The superior rate of Al18F-NOTA-FAPI-04 PET/CT imaging was higher than 18F-FDG imaging (P = 0.020). In subgroup of adult-onset Still's disease, 18F-FDG imaging showed better performance than Al18F-NOTA-FAPI-04 imaging. In most of the other subgroup of ARDs, Al18F-NOTA-FAPI-04 PET/CT imaging overperformed 18F-FDG imaging. CONCLUSION: Both 18F-FDG and Al18F-NOTA-FAPI-04 PET/CT imaging have excellent sensitivity in ARDs. The detection capabilities of two tracers varied according to the involving organs of ARDs. In most of ARDs except adult-onset Still's disease, Al18F-NOTA-FAPI-04 PET/CT imaging overperformed 18F-FDG imaging. Key Points • 18F-FDG and Al18F-NOTA-FAPI-04 PET/CT imaging have excellent sensitivity in diagnosing of ARDs. • 18F-FDG PET/CT imaging detected more lesions in lymph node, spleen, and bone marrow. • 18F-NOTA-FAPI-04 PET/CT imaging detected more lesions in the lung, muscle, and tendon/ligament. • 18F-NOTA-FAPI-04 PET/CT imaging overperformed18F-FDG in most subgroups of ARDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Rheumatic DiseasesAutoimmune DiseasesRadiopharmaceuticalsHumansFemaleMaleMiddle AgedAdultAgedProspective Studies

Stichwörter der Autor:innen

Fibroblast activation protein alphaFluorodeoxyglucose F18Positron emission tomographyRheumatic diseases

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Peking University Canc…
  • Department of Nuclear Medicine, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
  • Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Department of Nuclear Medicine, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. wangqian20135@163.com.

Förderung

  • Peking University People's Hospital scientific research development funds
  • Peking University People’s Hospital scientific research development funds

Zitieren

APA

Li, Y., Zhou, Y., He, J., Chen, J., Zhu, H., Yang, Z., Wang, Q., & Li, N. (2024). Head to head comparison of 18F-FDG and Al18F-NOTA-FAPI-04 PET/CT imaging used in diagnosis of autoimmune rheumatic diseases. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07155-4

Vancouver

Li Y, Zhou Y, He J, Chen J, Zhu H, Yang Z, et al. Head to head comparison of 18F-FDG and Al18F-NOTA-FAPI-04 PET/CT imaging used in diagnosis of autoimmune rheumatic diseases. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07155-4

BibTeX
@article{Li2024,
  author = {Li, Yuan and Zhou, Yunshan and He, Jing and Chen, Jinchuan and Zhu, Hua and Yang, Zhi and Wang, Qian and Li, Nan},
  title = {Head to head comparison of 18F-FDG and Al18F-NOTA-FAPI-04 PET/CT imaging used in diagnosis of autoimmune rheumatic diseases},
  journal = {Clinical Rheumatology},
  year = {2024},
  doi = {10.1007/s10067-024-07155-4}
}
Kostenlos starten →